Skip links

News

Blog: News

Explore PYFA’s end-to-end CDMO solutions, from product development and formulation to manufacturing, regulatory support, and market access—helping pharmaceutical partners bring innovative products to market efficiently across Indonesia and Asia-Pacific.

Supporting the Highest Retail Price (HET) Decision From the Government, PT Pyridam Farma Tbk. Prioritize the Production of Azithromycin and D3-1000 for Accelerating Healing of COVID-19 Patients
2 min read
During the First Quarter, Sales of PT. Pyridam Farma Tbk (PYFA) Up 49%
3 min read
South Korean Conglomerate Purchased Shares in PT Pyridam Farma Tbk (PYFA)
3 min read
LG International Corp (LGI) Signs Cooperation Agreement With PT Pyridam Farma Tbk (PYFA)
3 min read
Subsidiary of PT. Pyridam Farma Tbk (PYFA) Signed a Shares Subscription Agreement with Fullerton Healthcare Indonesia Group
4 min read
Positive Performance, Net Profit of PT. Pyridam Farma Tbk (PYFA) Increase 137%
4 min read
AMSI Receives 2,725 Supplement Packages from Pyridam Farma
5 min read
Pyridam Farma (PYFA) Ready to Enter the Consumer Health Market
2 min read
Supporting the Government Detecting the Spread of Covid-19 Pyridam Farma Provides Mobile PCR Lab at Tirta Medical Center
4 min read
Celebrating 44th Birthday, Pyridam Farma Changes Logo
4 min read